90 related articles for article (PubMed ID: 9145605)
1. Proliferating cell nuclear antigen immunostaining in breast carcinoma and its relationship to clinical and pathological variables.
Agarwal S; Jain R; Rusia U; Gupta RL
Indian J Pathol Microbiol; 1997 Jan; 40(1):11-6. PubMed ID: 9145605
[TBL] [Abstract][Full Text] [Related]
2. Comparative predictive value of three prognostic markers--S-phase fraction, PCNA and Mitotic count on axillary lymph node metastasis in carcinoma breast.
Pervez S; Khan MN; Nasir MI
J Ayub Med Coll Abbottabad; 2007; 19(1):3-5. PubMed ID: 17867469
[TBL] [Abstract][Full Text] [Related]
3. Correlation of proliferative index (PCNA reactivity and Ki-67 reactivity) in primary breast carcinoma with hormone status, lymph node status, and disease-free survival.
Magno WB; Hirschfield L; Bhuiya T; Harrison G; Mir R
Conn Med; 1992 Dec; 56(12):667-9. PubMed ID: 1363223
[TBL] [Abstract][Full Text] [Related]
4. Proliferation indices in spontaneous canine lung cancer: proliferating cell nuclear antigen (PCNA), Ki-67 (MIB1) and mitotic counts.
Griffey SM; Kraegel SA; Madewell BR
J Comp Pathol; 1999 May; 120(4):321-32. PubMed ID: 10208729
[TBL] [Abstract][Full Text] [Related]
5. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
6. PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma.
Gasparini G; Meli S; Pozza F; Cazzavillan S; Bevilacqua P
Growth Regul; 1992 Dec; 2(4):145-50. PubMed ID: 1363282
[TBL] [Abstract][Full Text] [Related]
7. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical assessment of proliferation rate of breast carcinoma cells using Ki-67, MIB-1 and anti-PCNA monoclonal antibodies.
Markiewski M; Domagała W
Pol J Pathol; 1996; 47(4):189-94. PubMed ID: 9097711
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinoma breast.
Aziz SA; Pervez S; Khan SM; Kayani N; Nasir MI
J Coll Physicians Surg Pak; 2005 Apr; 15(4):225-9. PubMed ID: 15857596
[TBL] [Abstract][Full Text] [Related]
10. [Immunohistochemical study of the proliferation of breast cancer cells based on the expression of proliferating cell nuclear antigen (PCNA)].
Uporov AV; Tsyrlina EV; Pozharisskiĭ KM
Vopr Onkol; 1998; 44(1):49-53. PubMed ID: 9578731
[TBL] [Abstract][Full Text] [Related]
11. Relationship between immunohistochemical evaluation of thymidylate synthase and proliferating cell nuclear antigen labeling index in gastrointestinal carcinoma.
Kunimoto Y; Nakamura T; Ohno M; Kuroda Y
Oncol Rep; 2004 Dec; 12(6):1163-7. PubMed ID: 15547732
[TBL] [Abstract][Full Text] [Related]
12. Proliferating cell nuclear antigen (PCNA) expression in laryngeal squamous cell carcinomas. An immunohistochemical study.
Kram A; Domagała W
Pol J Pathol; 1996; 47(4):183-7. PubMed ID: 9097710
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) expression in patients with breast carcinoma in comparison to patients with benign breast diseases.
Kalogeraki A; Tzardi M; Datseris G; Kanavaros P; Karvelas C; Chalkiadakis G; Tsiftsis D; Delides G
In Vivo; 1994; 8(6):1053-6. PubMed ID: 7772736
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical analysis of proliferating cell nuclear antigen (PCNA) in infiltrating ductal carcinomas: comparison with clinical and pathologic variables.
Frierson HF
Mod Pathol; 1993 May; 6(3):290-4. PubMed ID: 8102204
[TBL] [Abstract][Full Text] [Related]
15. [Proliferating cell nuclear antigen in cervical cancer and precursor lesions].
Wistuba I; Roa I; Araya JC; Villaseca M; Capurro I; Chávez F
Rev Med Chil; 1995 Sep; 123(9):1077-83. PubMed ID: 8728730
[TBL] [Abstract][Full Text] [Related]
16. PCNA--a cell proliferation marker in vocal cord cancer. Part II: Recurrence in malignant laryngeal lesions.
Broich G; Lavezzi AM; Biondo B; Pignataro LD
In Vivo; 1996; 10(2):175-8. PubMed ID: 8744797
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic significance of proliferation markers in hepatocellular carcinoma (HCC)].
Ebelt J; Neid M; Tannapfel A; Witzigmann H; Hauss J; Köckerling F; Wittekind C
Zentralbl Chir; 2000; 125(7):597-601. PubMed ID: 10960968
[TBL] [Abstract][Full Text] [Related]
18. Tumor proliferative fraction in infiltrating duct carcinoma.
Kesari AL; Chellam VG; Nair PP; Madhavan J; Nair P; Nair MK; Pillai MR
Gen Diagn Pathol; 1997 Dec; 143(4):219-24. PubMed ID: 9489954
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression in human breast cancer: an immunohistochemical study including correlation with cathepsin D, type IV collagen, laminin, fibronectin, EGFR, c-erbB-2 oncoprotein, p53, steroid receptors status and proliferative indices.
Ioachim EE; Athanassiadou SE; Kamina S; Carassavoglou K; Agnantis NJ
Anticancer Res; 1998; 18(3A):1665-70. PubMed ID: 9673387
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization and correlation of p53 and PCNA expression in breast carcinoma.
Goel MM; Goel R; Mehrotra A; Nath P; Agarwal PK; Singh K; Mehrotra R
Indian J Exp Biol; 2000 Mar; 38(3):225-30. PubMed ID: 10927863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
